Category

Daily Briefs

Daily Brief Industrials: Daehan Shipbuilding, Hanwha Engine, Nidec Corp, Ohba Co Ltd, Begbies Traynor, Northern Bear and more

By | Daily Briefs, Industrials

In today’s briefing:

  • KOSPI Size Indices: Lots of Change as Averaging Starts
  • Front-Running the Dec KOSPI 200: Heavy Industries Names Set Up the Real Flow Trade
  • Can Nidec (6594) Ever Wake Up from Its Compliance Nightmare?
  • Ohba (9765 Jp) – November 5, 2025
  • Begbies Traynor Group – Complementary acquisitions add to growth thesis
  • Hybridan Research: Northern Bear plc


KOSPI Size Indices: Lots of Change as Averaging Starts

By Brian Freitas

  • The review period for the March rebalance of the KOSPI Size Indices will commence on 1 December and will end on 28 February.
  • Nearing the start of the averaging period, we forecast 34 migrating stocks. Among new listings, 1 stock could be added to LargeCap, 2 to MidCap and 2 to SmallCap.
  • The upward migrations have outperformed the downward migrations by a lot over the last 3 months. The gap in returns versus the KOSPI2 INDEX is a lot smaller.

Front-Running the Dec KOSPI 200: Heavy Industries Names Set Up the Real Flow Trade

By Sanghyun Park

  • IT adds barely move (~0.1x DTV), but Heavy Industries pops: Sanil/Hanwha Engine draw ~0.4x DTV inflows, while Hanwha Vision faces ~0.6x DTV passive outflow.
  • June precedent: HD Marine Solution grabbed ~0.3x DTV extra inflow and ripped ~12% pre-rebalance, handily outperforming the tape and other KOSPI 200 adds.
  • Play the same setup: focus on Heavy Industries flow pockets—Sanil, Hanwha Engine, Hanwha Vision out—and eye entries starting Monday ahead of the Dec 8 go-live.

Can Nidec (6594) Ever Wake Up from Its Compliance Nightmare?

By Michael Allen

  • Until the latest accounting scandal, Nidec was just another stupidly over-valued company that chased too many rainbows and missed too many targets.
  • Now, finally, it has fallen to interesting valuations and there is a real incentive to fix the things that need fixing. 
  • Nidec is a governance nightmare with poor oversight, a history of bad strategic decisions, and shoddy execution. If these are fixed, though, the upside is enormous.

Ohba (9765 Jp) – November 5, 2025

By Sessa Investment Research

  • OHBA (hereafter, the Company) is a general construction consulting firm boasting a leading market share in the field of urban planning.
  • In the construction consulting industry, there were 56 companies with annual sales of JPY 5 bn or more and 106 companies with JPY 2 bn or more in the 12 months from January to December 2024.
  • The Company ranks 24th, positioning it as a mid-tier player. Over its century-long history, however, the Company has specialized in urban development fields such as city planning, and in this domain, it holds the top domestic market share, ahead of the runner-up, Nippon Koei Urban Space, by just under JPY 1 bn in annual sales.

Begbies Traynor Group – Complementary acquisitions add to growth thesis

By Equity Development

  • Begbies has announced two acquisitions this week for a maximum consideration of £9.25m, adding to its property advisory and transactional services division, Eddisons.
  • In keeping with Begbies’ strategy for value-accretive acquisitions that add services or geographies, Begbies is paying c.1.0x EV/Sales for an additional c.4% of sales.
  • The £8.25m acquisition of Kirkby Diamond LLP and Kirkby Diamond Property Management, (together adds five, complementary, office locations along the M1 corridor and all 62 staff will join Begbies Traynor.

Hybridan Research: Northern Bear plc

By Hybridan

  • The Interims to September 2025 exceeded expectations with a resilient underlying trading performance across all divisions helped by the ongoing strategic operational investments.
  • This performance was further amplified by a £1.3m non-recurring profit (N-RP) accounted for in H126.
  • This N-RP is included with operating profits; earnings comparisons are therefore extra-ordinary.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Biogen Inc, D.Western Therapeutics Institute Inc., InxMed, Eisai Co Ltd, Organigram Holdings and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Biogen’s $50 Million Immunology Power Move: Are Oral Peptides The Future?
  • D. Western Therapeutics Institute (DWTI) (4576 JP) – November 21, 2025
  • Pre-IPO InxMed – The Pipeline and the Outlook
  • Eisai Co Ltd (4523 JP): Label Expansion Drives Leqembi Ahead; Competitive Landscape Turns Favorable
  • Primer: Organigram Holdings (OGI US) – Nov 2025


Biogen’s $50 Million Immunology Power Move: Are Oral Peptides The Future?

By Baptista Research

  • Biogen Inc. has made headlines with its latest strategic maneuver: a $50 million research partnership with Dayra Therapeutics, a biotech innovator specializing in macrocyclic peptides.
  • This move signals Biogen’s intensified push into the immunology space, a significant pivot from its traditional focus on neuroscience.
  • The deal gives Biogen early access to a platform designed to develop oral treatments for autoimmune and inflammatory conditions—categories currently dominated by injectable therapies.

D. Western Therapeutics Institute (DWTI) (4576 JP) – November 21, 2025

By Sessa Investment Research

  • SIR believes DWTI has entered an exciting new phase given significant advances in pipeline development achieved over the last year.
  • Key advances included: 1) publishing favorable topline results of in-house developed glaucoma treatment [H- 1337] Phase IIb US trials (strong prospects as “first choice as a second-line drug”)
  • 2) commenced joint development Japan Phase II clinical trials of regenerative cell therapy [DWR-2206] with ActualEyes, and successfully completed all transplants

Pre-IPO InxMed – The Pipeline and the Outlook

By Xinyao (Criss) Wang

  • FAK inhibitors’ R&D is not smooth.The breakthrough in FAK clinical protocol lies in the possibility of finding new application scenarios, such as the potential for combination with various anticancer drugs.
  • If ifebemtinib can be successfully approved for 2-3 core indications (e.g. PROC, NSCLC) and enter medical insurance smoothly, its sales peak in the China market may reach RMB2-3 billion.
  • Post-Money valuation after Series C Financing was USD306 million. The issuance valuation of InxMed may be given a certain premium on top of Series C valuation, such as US$350-500 million.

Eisai Co Ltd (4523 JP): Label Expansion Drives Leqembi Ahead; Competitive Landscape Turns Favorable

By Tina Banerjee

  • Eisai Co Ltd (4523 JP) recorded153% YoY revenue growth to ¥41B for Leqembi during H1FY26, driven by significant growth in Japan (+177% YoY) and Americas (+84% YoY).
  • For FY26, Eisai has guided for Leqembi revenue of ¥77B, up 73% YoY.  H1FY26 Leqembi revenue represents progress rate of more than 50%, thereby raising conviction of meeting full-year guidance.
  • Recent clinical trial setbacks suffered by two large players, Johnson & Johnson and Novo Nordisk should act in favor of Leqembi.  

Primer: Organigram Holdings (OGI US) – Nov 2025

By αSK

  • Organigram is a leading Canadian licensed cannabis producer well-positioned to capitalize on the growing legal cannabis market, with a strong focus on product innovation and expanding its international footprint.
  • The company has demonstrated significant revenue growth and has a strategic partnership with British American Tobacco (BAT), providing substantial capital for research and development and global expansion efforts.
  • Despite a challenging Canadian market characterized by intense competition and price compression, Organigram’s focus on operational efficiency and cost management is driving it towards sustained profitability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Naver Corp, Kioxia Holdings , Amazon, Suzhou Novosense Microelectron, Dell Technologies , JD Industrial Technology , Dynatrace , TSMC (Taiwan Semiconductor Manufacturing) – ADR, Alphawave IP Group, Artificial Intelligent Interconnection Technology and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Naver Financial and Dunamu Finalizes the Merger Ratio
  • KIOXIA (285A JP) — Q2 FY25 Update, Selldown Context, and Valuation
  • Amazon’s New AI Fortress: A $50 Billion Investment In Data Centres To Transform Government Computing!
  • Suzhou Novosense A/H Listing – Growth Has Been Strong but Margins Weak
  • PC Monitor: Dell/HP Results Support PC Up-Cycle Into 2026E
  • JD Industrials Pre-IPO – Updated Peer Comparison and Thoughts on Valuations
  • Dynatrace: ServiceNow & Atlassian Partnerships Could Transform Its Growth Trajectory!
  • Taiwan Tech Weekly: Rapidus Making Progress… TSMC Impact; Latest PC Results Support 2026E Up-Cycle
  • Alphawave: Fully Valued, Waiting for the Wire
  • Artificial Intelligent Interconnection Technology Pre-IPO Tearsheet


Naver Financial and Dunamu Finalizes the Merger Ratio

By Douglas Kim

  • On 26 November, Naver Financial and Dunamu finalized the merger ratio. Under the proposed share swap, one share of Dunamu will be exchanged for 2.54 shares of Naver Financial. 
  • Dunamu’s equity value is 15.1 trillion won, and Naver Financial’s is 4.9 trillion won.
  • Overall, we have a positive view of this merger and it is likely to positively impact Naver’s share price as well. 

KIOXIA (285A JP) — Q2 FY25 Update, Selldown Context, and Valuation

By Rahul Jain

  • Q2 results confirmed a clear earnings inflection, driven by strong enterprise SSD demand, improving ASPs, and recovering smartphone NAND volumes.
  • Q3 guidance signals record revenue and further margin expansion supported by tight NAND supply and AI-linked storage demand.
  • Despite near-term pressure from Bain’s selldown, long-term fundamentals remain intact; valuation discounts justify a ¥12,500 target and accumulate-on-weakness stance.

Amazon’s New AI Fortress: A $50 Billion Investment In Data Centres To Transform Government Computing!

By Baptista Research

  • Amazon.com reported robust financial results for the third quarter of 2025, highlighting both progress and challenges across its business segments.
  • Total revenue reached $180.2 billion, marking a year-over-year increase of 12% when adjusting for foreign exchange impacts.
  • Operating income was reported at $17.4 billion, however, this was impacted by two significant expenses: a $2.5 billion FTC settlement and $1.8 billion in estimated severance costs.

Suzhou Novosense A/H Listing – Growth Has Been Strong but Margins Weak

By Sumeet Singh

  • Suzhou Novosense Microelectron (688052 CH), an analog chips producer, aims to raise around US$500m in its H-share listing.
  • According to Frost & Sullivan, in terms of revenue from analog chips in 2024, SNM ranked fifth among Chinese analog chip companies in the Chinese analog chip market.
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

PC Monitor: Dell/HP Results Support PC Up-Cycle Into 2026E

By Vincent Fernando, CFA

  • AI PCs turning the PC refresh into a gradual, extended up-cycle
  • Memory inflation is one of the major margin risks for PC makers in 2026
  • Dell’s server business indicates AI factory build-outs becoming a multi-year investment cycle. Remain long Dell, Asustek, Acer.

JD Industrials Pre-IPO – Updated Peer Comparison and Thoughts on Valuations

By Sumeet Singh

  • JD Industrial Technology is now looking to raise about US$500m in its upcoming HK IPO.
  • JDI is a leading industrial supply chain technology and service provider in China in terms of GMV in each year during the Track Record Period, according to CIC.
  • We have looked at the company background and refiling updates in our previous notes. In this note, we will talk about the refiling updates.

Dynatrace: ServiceNow & Atlassian Partnerships Could Transform Its Growth Trajectory!

By Baptista Research

  • Dynatrace recently reported its fiscal second quarter of 2026 results, showcasing a robust performance that exceeded its guidance across various metrics.
  • The company reported a 16% growth in Annual Recurring Revenue (ARR), a 17% growth in subscription revenue, and a pretax free cash flow representing 32% of revenue on a trailing 12-month basis.
  • Such strong results underline the company’s successful strategy execution, driven by growing demand in end-to-end observability and multi-cloud tool consolidation.

Taiwan Tech Weekly: Rapidus Making Progress… TSMC Impact; Latest PC Results Support 2026E Up-Cycle

By Vincent Fernando, CFA

  • Japan’s Rapidus Moves Ahead With 1.4nm Plans… TSMC Impact? — Latest and Past Analysis
  • PC Monitor: Latest Dell/HP Results Support PC Up-Cycle Into 2026E 
  • TechChain Insights: Factory Visit with One of Taiwan’s Critical Battery Suppliers  

Alphawave: Fully Valued, Waiting for the Wire

By Jesus Rodriguez Aguilar

  • Qualcomm’s $2.48/share offer for Alphawave is fully recommended and cleared by regulators, with completion expected mid-December. FX-linked cash value limits remaining upside; no sweetener or bump indicated.
  • Alphawave shares now trade above implied value, reflecting full deal certainty. Arbitrage returns attractive only for early entrants; current negative spread makes new positions unattractive.
  • Founders aligned via exchangeable securities; structure supports completion. Qualcomm gains SerDes IP and custom silicon capabilities for AI data center growth, diversifying away from mobile reliance.

Artificial Intelligent Interconnection Technology Pre-IPO Tearsheet

By Hong Jie Seow

  • Artificial Intelligent Interconnection Technology (AII HK)  (AIIT) is looking to raise about US$200m in its upcoming Hong Kong IPO. The deal will be run by CITIC and CCB International.
  • Artificial Intelligent Interconnection Technology (AIIT) is a provider of AI technology, products, and spatial intelligence solutions in China, with a particular strength in high-precision AI-based urban traffic management.
  • Its solutions combine hardware, software, and scenario-derived datasets to deliver full-stack AI systems that improve traffic efficiency, safety, and the management of public spaces.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Daehan Shipbuilding, Hanwha Engine, Nidec Corp, Ohba Co Ltd, Begbies Traynor, Northern Bear and more

By | Daily Briefs, Industrials

In today’s briefing:

  • KOSPI Size Indices: Lots of Change as Averaging Starts
  • Front-Running the Dec KOSPI 200: Heavy Industries Names Set Up the Real Flow Trade
  • Can Nidec (6594) Ever Wake Up from Its Compliance Nightmare?
  • Ohba (9765 Jp) – November 5, 2025
  • Begbies Traynor Group – Complementary acquisitions add to growth thesis
  • Hybridan Research: Northern Bear plc


KOSPI Size Indices: Lots of Change as Averaging Starts

By Brian Freitas

  • The review period for the March rebalance of the KOSPI Size Indices will commence on 1 December and will end on 28 February.
  • Nearing the start of the averaging period, we forecast 34 migrating stocks. Among new listings, 1 stock could be added to LargeCap, 2 to MidCap and 2 to SmallCap.
  • The upward migrations have outperformed the downward migrations by a lot over the last 3 months. The gap in returns versus the KOSPI2 INDEX is a lot smaller.

Front-Running the Dec KOSPI 200: Heavy Industries Names Set Up the Real Flow Trade

By Sanghyun Park

  • IT adds barely move (~0.1x DTV), but Heavy Industries pops: Sanil/Hanwha Engine draw ~0.4x DTV inflows, while Hanwha Vision faces ~0.6x DTV passive outflow.
  • June precedent: HD Marine Solution grabbed ~0.3x DTV extra inflow and ripped ~12% pre-rebalance, handily outperforming the tape and other KOSPI 200 adds.
  • Play the same setup: focus on Heavy Industries flow pockets—Sanil, Hanwha Engine, Hanwha Vision out—and eye entries starting Monday ahead of the Dec 8 go-live.

Can Nidec (6594) Ever Wake Up from Its Compliance Nightmare?

By Michael Allen

  • Until the latest accounting scandal, Nidec was just another stupidly over-valued company that chased too many rainbows and missed too many targets.
  • Now, finally, it has fallen to interesting valuations and there is a real incentive to fix the things that need fixing. 
  • Nidec is a governance nightmare with poor oversight, a history of bad strategic decisions, and shoddy execution. If these are fixed, though, the upside is enormous.

Ohba (9765 Jp) – November 5, 2025

By Sessa Investment Research

  • OHBA (hereafter, the Company) is a general construction consulting firm boasting a leading market share in the field of urban planning.
  • In the construction consulting industry, there were 56 companies with annual sales of JPY 5 bn or more and 106 companies with JPY 2 bn or more in the 12 months from January to December 2024.
  • The Company ranks 24th, positioning it as a mid-tier player. Over its century-long history, however, the Company has specialized in urban development fields such as city planning, and in this domain, it holds the top domestic market share, ahead of the runner-up, Nippon Koei Urban Space, by just under JPY 1 bn in annual sales.

Begbies Traynor Group – Complementary acquisitions add to growth thesis

By Equity Development

  • Begbies has announced two acquisitions this week for a maximum consideration of £9.25m, adding to its property advisory and transactional services division, Eddisons.
  • In keeping with Begbies’ strategy for value-accretive acquisitions that add services or geographies, Begbies is paying c.1.0x EV/Sales for an additional c.4% of sales.
  • The £8.25m acquisition of Kirkby Diamond LLP and Kirkby Diamond Property Management, (together adds five, complementary, office locations along the M1 corridor and all 62 staff will join Begbies Traynor.

Hybridan Research: Northern Bear plc

By Hybridan

  • The Interims to September 2025 exceeded expectations with a resilient underlying trading performance across all divisions helped by the ongoing strategic operational investments.
  • This performance was further amplified by a £1.3m non-recurring profit (N-RP) accounted for in H126.
  • This N-RP is included with operating profits; earnings comparisons are therefore extra-ordinary.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: National Storage REIT, APlus Asset Advisor, Jones Lang Lasalle, Vanke Property Overseas, Kenedix Inc and more

By | Daily Briefs, Financials

In today’s briefing:

  • National Storage REIT (NSR AU): Brookfield and GIC’s Attractive NBIO at A$2.86
  • M&A Battle for APlus Asset Advisor Heats Up Amid Tender Offer
  • JLL Inside the Leasing Comeback: How the Firm Is Securing Bigger, Faster Deals!
  • Primer: Vanke Property Overseas (1036 HK) – Nov 2025
  • Primer: Kenedix Inc (4321 JP) – Nov 2025


National Storage REIT (NSR AU): Brookfield and GIC’s Attractive NBIO at A$2.86

By Arun George

  • National Storage REIT (NSR AU) has received a non-binding proposal from Brookfield and GIC at A$2.86 per unit, a 26.5% premium to the undisturbed price.
  • The Board has granted exclusive due diligence until 7 December. A scheme offer would be conditional on FIRB, NZ OIO and ACCC approval. 
  • The offer is attractive as it represents an all-time high and implies a P/NTA of 1.11x. The short exclusivity period increases the odds of a binding proposal.

M&A Battle for APlus Asset Advisor Heats Up Amid Tender Offer

By Douglas Kim

  • There appears to be a M&A battle heating up for APlus Asset Advisor. This is because it was reported that Aplus Asset Advisor Chairman Kwak Geun-ho has increased his stake.
  • Chairman Kwak Geun-ho purchased additional 30,904 shares of Aplus Asset’s common stock over three trading days and his stake increased by 0.14 percentage points from 20.06% to 20.20%.
  • In the next 3-6 months, we expect additional upside to the stock price (to 10,000 won to 12,000 won) as more investors perceive this could be an attractive M&A target.

JLL Inside the Leasing Comeback: How the Firm Is Securing Bigger, Faster Deals!

By Baptista Research

  • Jones Lang LaSalle Incorporated (JLL) has reported robust third-quarter results for 2025, marking continued growth and momentum across its diverse real estate services and investment management operations.
  • The firm continues to benefit from its expansive global presence and diversified platform, emphasizing strong investment in technology as a key differentiator in enhancing productivity and client solutions.
  • During the third quarter, JLL achieved a 10% increase in revenue and a 16% rise in adjusted EBITDA, contributing to a 29% climb in adjusted earnings per share (EPS).

Primer: Vanke Property Overseas (1036 HK) – Nov 2025

By αSK

  • Vanke Property Overseas serves as the international asset management and property development arm for its parent, China Vanke, focusing on prime global cities but facing significant headwinds from the broader Chinese real estate crisis.
  • The company’s financial performance shows a concerning trend, with a sharp decline into a net loss in the latest reported year despite revenue growth, alongside collapsing margins and a reduced dividend, reflecting severe market pressures.
  • Valuation appears distressed, with a very low price-to-book ratio; however, high uncertainty in the Chinese and Hong Kong property markets, coupled with negative profitability and growth trends, suggests significant risks for investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Kenedix Inc (4321 JP) – Nov 2025

By αSK

  • Historical Analysis of a Delisted Entity: This report provides a historical analysis of Kenedix Inc. (4321 JP), a former publicly traded real estate asset management company. The company was delisted from the Tokyo Stock Exchange on March 17, 2021, following a successful tender offer and privatization. Therefore, this primer serves as a post-mortem analysis for institutional investors, examining the firm’s operations and financial standing leading up to its acquisition.
  • Privatization Led by SMFL and ARA: In November 2020, Sumitomo Mitsui Finance and Leasing (SMFL), a subsidiary of Sumitomo Mitsui Financial Group, launched a takeover bid for Kenedix, in partnership with the then-largest shareholder, ARA Asset Management. The tender offer was successful, leading to SMFL acquiring a 70% stake and ARA increasing its holding to 30%. Subsequently, in October 2025, SMFL’s subsidiary, SMFL MIRAI Partners, acquired the remaining 30% from ESR (which had acquired ARA), making Kenedix a wholly-owned subsidiary.
  • Pre-Acquisition Business Focus: Prior to its delisting, Kenedix was one of Japan’s largest independent real estate asset management firms, managing a diverse portfolio through publicly-listed J-REITs, private REITs, and private funds. The company operated an ‘asset-light’ model, focusing on generating stable asset management fees rather than direct property ownership, with a significant concentration of assets in the Tokyo metropolitan area.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Toyoda Gosei, Human Made, Ingdan, Haier Smart Home , Busy Ming Group, US Foods Holding Corp, Guess? Inc, Kimly Ltd, Kingfisher PLC, Creightons and more

By | Consumer, Daily Briefs

In today’s briefing:

  • [Japan Offering] Toyota Selling Down Toyoda Gosei (7282) In BIG Offering; 85d ADV, 125% of Max RWF
  • Human Made IPO: Making A Fashion Statement With Premium Valuation
  • Ingdan (400 HK) Reloads Comtech’s Spin-Off and Listing
  • Haier Smart Home (6690 HK) – Steady Execution to Win the Race
  • Busy Ming IPO Update: Cash-Generating Machine With Improving Gross Margins, IPO Is on the Horizon
  • US Foods Ends Mega Merger Talks With Performance Food—What’s Next?
  • GES: With Terms Fully Set, Time to Bow Out; Dropping Coverage of GES
  • Kimly: Results Slightly Better than Expected
  • Kingfisher plc – Strategy driving profit upgrades despite soft markets
  • Hybridan Small Cap Feast: 19 November 2025


[Japan Offering] Toyota Selling Down Toyoda Gosei (7282) In BIG Offering; 85d ADV, 125% of Max RWF

By Travis Lundy

  • Last week, before the long weekend, Toyota Motor (7203 JP) and Sumitomo Mitsui Financial Group (8316 JP) announced a very big secondary selldown of shares in Toyoda Gosei (7282 JP)
  • The selldown is 85x 3mo ADV, 27% of shares out. 125% of Max Real World Float. It’s a lot of stock at $750mm. One wonders where demand is.
  • They also announced a big buyback, which is some of it, and there are index impacts, BUT this offering needs to find LOTS of new fundamental owners quickly.

Human Made IPO: Making A Fashion Statement With Premium Valuation

By Hong Jie Seow

  • Human Made (456A JP) raised US$116m in its Japan IPO.
  • Human Made Inc. is a Japan-based apparel and lifestyle company. Its business model centers on producing high-value, limited-supply apparel and goods. 
  • In our previous note, we looked at its past performance and valuations. In this note, we will talk about the trading dynamics.

Ingdan (400 HK) Reloads Comtech’s Spin-Off and Listing

By David Blennerhassett

  • Technology platform play Ingdan (400 HK) is moving ahead, again, with the spin-off and listing of 72.42%-held Shenzhen Comtech in the PRC. 
  • The listing – should it go ahead, as the previous attempt was abandoned – is expected to involve the issuance of new shares. Ingdan will maintain a stake in Comtech. 
  • Comtech accounted for 95% of Ingdan’s revs in the 1H25. Expect the market to heavily discount Ingdan’s stub ops, and Ingdan’s NAV post spin-off. 

Haier Smart Home (6690 HK) – Steady Execution to Win the Race

By Sreemant Dudhoria,CFA

  • Solid Q3 and 9M FY25 Financial Delivery: Despite challenging market conditions in China, Haier Smart Home (6690 HK) delivered solid third-quarter results reinforcing company’s strategic positioning and operational execution.
  • Operational Efficiency and Mix Upgrade: The company continued to benefit from digitalised manufacturing, supply-chain optimisation, and higher contribution from high-end segments, supporting EBITDA and net profit resilience despite macro softness
  • Strategic Focus Driving Sustainable Growth:Emphasis on Smart Home ecosystem expansion, global penetration, and disciplined capital allocation reinforce its competitive positioning and sets the foundation for sustained earnings momentum into FY26.

Busy Ming IPO Update: Cash-Generating Machine With Improving Gross Margins, IPO Is on the Horizon

By Andrei Zakharov

  • Busy Ming Group, a founder-led food and beverage chain retailer in China with strong presence in third- and lower-tier cities, filed the updated Application Proof in October.
  • In the six months ended Jun-25, the company’s revenue was ~RMB28,124m, representing a year-over-year growth of ~87%. LTM net profit was ~RMB2,025m.
  • Busy Ming Group enjoys superior growth profile coupled with improving gross profit margins. The company ended Aug-25 with RMB3,393m net cash on the balance sheet.  

US Foods Ends Mega Merger Talks With Performance Food—What’s Next?

By Baptista Research

  • US Foods and Performance Food Group have officially ended their merger discussions, closing the door on what could have been the most consequential consolidation event in modern food‑distribution history.
  • After months of due diligence and information‑sharing, both companies independently concluded that pursuing their standalone strategies would create greater long‑term shareholder value than combining into a $30 billion foodservice powerhouse capable of rivaling Sysco.
  • The decision follows heightened regulatory considerations, diverging strategic priorities, and each company’s confidence in its independent business trajectory.

GES: With Terms Fully Set, Time to Bow Out; Dropping Coverage of GES

By Small Cap Consumer Research

  • We are dropping research coverage of GES after the company reported strong 3Q results (handily beating the Street in almost every level) but, more importantly, provided the final pieces to the merger puzzle timing and return.
  • With Guess?
  • disclosing the November 21st approval of the Merger Agreement at a special shareholder meeting and the issuance of a final $0.225 per GES share dividend to shareholders of record on December 10th, the management buyout with leading brand licensee Authentic Brands Group will provide GES shareholders with a confirmed final payment of $16.975 in cash per GES share ($16.75 for the merger and dividend of $0.225) a slight discount to Tuesday’s closing price.

Kimly: Results Slightly Better than Expected

By Punit Khanna

  • No surprises in the results, margins better than our anticipation
  • Business continues to be steady & the company has negative working capital
  • Kimly maintained dividend of 2 cents with a yield of 5.1% 

Raising Money for Persons with Disabilities in Singapore

For your kind consideration

This report has been prepared by Vriddhi Consulting, founded by Punit and Debjani Khanna. A portion of the research was contributed by Shubham Khanna, an individual on the autism spectrum.  We are grateful to Smartkarma for providing a platform to share this research and amplify its impact.

All proceeds from the publication of this report will be donated to support people with disabilities in Singapore. If you find this report valuable, we invite you to support our campaign, “Raising Money for Persons with Disabilities in Singapore.” Every contribution directly benefits the Goh Chok Tong Enable Fund and qualifies for a 250% tax deduction for Singapore tax residents.

To contribute, please visit this URL. 


Kingfisher plc – Strategy driving profit upgrades despite soft markets

By Equity Development

  • Kingfisher’s 3Q26 sales growth of 1.0%, including LFL +0.9%, was better than expected and driven by market share gains in UK.
  • In addition, the group’s investments in e-commerce and trade continued to deliver double digit growth across the group as self-help actions helped offset soft markets, particularly in France and Poland.
  • Building on the strong profit performance in H126, management has upgraded FY26E Adj. PBT guidance again, to £540m-£570m.

Hybridan Small Cap Feast: 19 November 2025

By Hybridan

  • The beauty and well-being brand owner and manufacturer, reports interims to September 2025.
  • Revenue marginally increased by £0.1m to £27.2m with 15.4% growth to £2.2m in private labels resulting from new retailers and category expansion.
  • This was offset by a decline in contract manufacturing. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Samsung Electronics, Smec Co Ltd, POSCO Holdings, SK Biopharmaceuticals , LOTTE Corporation, Shinyoung Securities and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Confirmation of Cancellation of Treasury Shares To Be Made Into Law by End of 2025 and a Loophole?
  • SMEC (099440 KS) Pops As SNT Shifts Its Intent
  • POSCO Holdings: Selling Remaining Stake in Nippon Steel in a Block Deal Sale
  • SK Biopharmaceuticals (326030 KS): Swelling Xcopri Sales in US Drives Record High 3Q Earnings
  • Lotte Corp: Worsening Balance Sheet Offset by Its High Treasury Shares Level
  • Primer: Shinyoung Securities (001720 KS) – Nov 2025


Confirmation of Cancellation of Treasury Shares To Be Made Into Law by End of 2025 and a Loophole?

By Douglas Kim

  • On 25 November, the Democratic Party of Korea confirmed that the cancellation of treasury shares will be made into law by the end of 2025.
  • Companies that buyback their shares (as treasury shares) will be required to cancel them within one year of the buyback. 
  • There may be a LOOPHOLE if the company fails to cancel the treasury shares on time. Fine per director is only 50 million won and this may be too low. 

SMEC (099440 KS) Pops As SNT Shifts Its Intent

By David Blennerhassett

  • SNT Holdings (036530 KS) has lifted its stake in SMEC (099440 KS), South Korea’s second-largest machine tool manufacturer, to 13.65% from 8.19%. SNT’s chairman also holds 6.55%, or 20.2% all-in.
  • Concurrent with the stake increase, SNT formally declared its equity holding in SMEC to  “management participation” from “simple investment“. 
  • The move could simply be one of SNT aligning its interests with SMEC’s management. But more likely, it’s a precursor to a potential hostile takeover. SMEC is now up ~40%.

POSCO Holdings: Selling Remaining Stake in Nippon Steel in a Block Deal Sale

By Douglas Kim

  • After the market close on 25 November, it was reported that POSCO Holdings is selling its remaining stake in Nippon Steel Corporation in a block deal sale.
  • The block deal sale involves selling the remaining 39.2 million shares of Nippon Steel. The deal is valued at 24.2 billion yen (approximately 227 billion won). 
  • Given the overall negative sentiment on POSCO’s potential acquisition of HMM, until this uncertainty is resolved, POSCO Holdings’ share price could continue to face stiff headwinds. 

SK Biopharmaceuticals (326030 KS): Swelling Xcopri Sales in US Drives Record High 3Q Earnings

By Tina Banerjee

  • SK Biopharmaceuticals (326030 KS) reported record high quarterly earnings in 3Q25 on surging U.S. sales of Xcopri, which surpassed quarterly revenue of $100M for the second time.
  • Revenue from Xcopri in the U.S. increased 52% YoY (accelerated from 47% YoY reported in 2Q25) and 12% QoQ to record high of KRW172B, on enhanced marketing efforts.
  • For full-year 2025, SKBP guided for Xcopri U.S. revenue of $420–450M (~KRW570–610B), up 31–40% YoY. During first nine months of 2025, Xcopri U.S. revenue reached $325M (KRW460M).

Lotte Corp: Worsening Balance Sheet Offset by Its High Treasury Shares Level

By Douglas Kim

  • Despite the higher probability of the cancellation of treasury shares by Lotte Corp, we believe that its worsening balance sheet is a greater concern. 
  • There does not appear to be a rapid business turnaround of its major affiliates including Lotte Chemical. As a result, we are concerned about further credit downgrades in 2026/2027.
  • Our base case NAV valuation of Lotte Corp is market cap of 2.2 trillion won or target price of 20,918 won per share, which is 29% lower than current price.

Primer: Shinyoung Securities (001720 KS) – Nov 2025

By αSK

  • Shinyoung Securities demonstrates a compelling value proposition with a low price-to-book ratio and a consistent, high dividend yield, appealing to value and income-oriented investors.
  • Despite strong multi-year growth in net income and EPS, the company exhibits significant top-line volatility and deeply negative operating cash flows, raising concerns about the quality and sustainability of its earnings.
  • The firm operates in the highly competitive and cyclical South Korean securities industry, facing pressures on margins and earnings streams that are heavily influenced by macroeconomic conditions and market trading volumes.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Iress Ltd, National Storage REIT, Intermin Resources, Island Pharmaceuticals , Monadelphous and more

By | Australia, Daily Briefs

In today’s briefing:

  • Iress (IRE AU): Suitors Engaged, But (Still) Nothing Firm
  • National Storage REIT (NSR AU) In Trading Halt Ahead Of Possible Brookfield/GIC Tilt
  • Horizon Minerals Ltd – Production Update
  • Island Pharmaceuticals Ltd – De-risking the commercial path
  • Primer: Monadelphous (MND AU) – Nov 2025


Iress (IRE AU): Suitors Engaged, But (Still) Nothing Firm

By David Blennerhassett

  • The board of Iress Ltd (IRE AU), a trading and wealth management software provider, has denied reports in an Australian article concerning a possible takeover from Blackstone. 
  • The article said that Blackstone was reportedly back in talks for a bid “that could be worth between $11 and $12 per share“. Iress’ share price promptly popped 8% yesterday. 
  • Iress is still very much in play as it “continues to engage with multiple parties“. 

National Storage REIT (NSR AU) In Trading Halt Ahead Of Possible Brookfield/GIC Tilt

By David Blennerhassett

  • Reportedly, Brookfield and Singapore’s GIC will make an Offer for National Storage REIT (NSR AU), Australia and New Zealand’s largest landlord of self-storage sites .
  • The AFR is reporting that Brookfield/GIC are on the cusp of launching a bid around NTA.  NSR entered into a trading halt this morning. 
  • Earlier this year, key peer Abacus Storage King (ASK AU) fielded an NBIO from Ki Corporation/Public Storage (PSA US) at a ~3% premium to NTA; however, Ki/PSA ultimately walked. 

Horizon Minerals Ltd – Production Update

By RaaS Research Group (RaaS)

  • Horizon Minerals Limited (ASX:HRZ) is an emerging junior gold producer with 1.8moz of gold resources located around the Kalgoorlie and Coolgardie regions of Western Australia.
  • HRZ has announced a production update for both the Boorara and Phillips Find JV mining operations.
  • The update details progression on mining and processing at both projects as well as further detail on forward expectations which we think helps guide investors towards understanding ultimate outcomes.

Island Pharmaceuticals Ltd – De-risking the commercial path

By RaaS Research Group (RaaS)

  • Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
  • The company has made two recent announcements that improve its chances of selling Galidesivir for Marburg to the US government, ahead of potential FDA clearance of the drug.
  • On 20 November 2025 it announced the appointment of leading Washington D.C. based federal government affairs and lobbying firm, Todd Strategy Group (TSG), to support US government engagement.

Primer: Monadelphous (MND AU) – Nov 2025

By αSK

  • Monadelphous is a leading Australian engineering group specializing in construction and maintenance services for the resources, energy, and infrastructure sectors. Its dual-division structure allows it to capture opportunities across the full asset lifecycle.
  • The company is experiencing a period of strong growth, driven by significant contract wins in its core markets, particularly in iron ore and energy. A robust project pipeline and strategic acquisitions are expected to support continued revenue momentum.
  • While exposed to the cyclical nature of the resources sector and persistent skilled labor shortages, Monadelphous‘ strong balance sheet, long-term client relationships with blue-chip companies, and diversification into renewable energy and critical minerals position it to navigate market uncertainties.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Priority Technology Holdings I, NVIDIA Corp, Gold, Dominion Energy Inc, Life Time Group Holdings, IonQ , Rigetti Computing , Abbott Laboratories and more

By | Daily Briefs, United States

In today’s briefing:

  • Priority Technology Faces Management Buyout Proposal Amid Activist Opposition
  • How Much of Nvidia’s Demand Is Nvidia-Enabled?
  • GOLD Tactical Outlook: Profit Targets for December 2025
  • Sold Out Yet Stockpiled: Nvidia’s Q3 Highlights Potential Deployment Limits
  • Dominion Energy Is Targeting NOVEC—Here’s Why That Should Get Everyone’s Attention!
  • Life Time Inc. Unleashes a High-End Expansion—Is Its Affluent Club Strategy a Game Changer?
  • IonQ Inc: How Europe & NATO Expansion Could Unlock Massive New Revenue Streams!
  • Management Buyouts and Litigation Updates: PRTH, KNOP, LEN, ABCP, and NANO Developments in Focus
  • Back to Near-Term Bullish on SPX and Nasdaq 100; Supports Held at SPX 6480-6520 and QQQ $580-583
  • Abbott Labs’ Exact Sciences Acquisition: What Could Go Right In This $21 Billion Cancer Play?


Priority Technology Faces Management Buyout Proposal Amid Activist Opposition

By Special Situation Investments

  • Priority Technology received a non-binding privatization offer from founder Thomas Priore at $6-$6.15/share, with Priore owning 58%.
  • Activists Buckley Capital and Steamboat Capital oppose the bid, claiming it undervalues PRTH, suggesting a fair value of $10-$17/share.
  • The company’s segments include Merchant Solutions, Payables, and Treasury Solutions, with 64% of adjusted gross profit from recurring revenues.

How Much of Nvidia’s Demand Is Nvidia-Enabled?

By Raghav Vashisht

  • Nvidia’s multi-year cloud service commitments jumped from $12.6B to $26B in one quarter, but only $1B is due in cash before late FY26, raising questions about the immediacy of demand.
  • Nvidia is backstopping customer infrastructure via an $860M facility lease guarantee, with only $470M escrowed; effectively transferring counterparty credit risk onto Nvidia’s balance sheet.
  • Structurally, this resembles circular financing, where customers take on debt (facilitated by Nvidia) to secure future compute capacity, enabling Nvidia to book future revenue while cash conversion lags.

GOLD Tactical Outlook: Profit Targets for December 2025

By Nico Rosti

  • Gold (GOLD COMDTY) this week has resumed its uptrend after a brief, shallow setback in mid-November.
  • This insight will analyze our Gold Futures Dec 25 model to determine profit targets that could be reached in the next 3 weeks (in December 2025).
  • Range: Gold could reach again previous highs, in December, while if it goes down it could reach the 3933 support zone.

Sold Out Yet Stockpiled: Nvidia’s Q3 Highlights Potential Deployment Limits

By Raghav Vashisht

  • Nvidia is transitioning from a GPU vendor to a full-stack systems supplier for AI infrastructure, with the Data Centre segment driven more by integrated rack-scale deployments than standalone accelerators.
  • Management positions Nvidia as the reference architecture for a “$3–4 trillion annual AI infrastructure build”, but finished goods inventories are up 90%+ amid “sold-out cloud capacity.”
  • The rapid shift toward rack-scale systems introduces new ecosystem tensions, as Nvidia’s move into full system design increasingly overlaps with the domain of OEM partners.

Dominion Energy Is Targeting NOVEC—Here’s Why That Should Get Everyone’s Attention!

By Baptista Research

  • Dominion Energy is accelerating into one of the most consequential growth phases in its history, with data centerdriven load growth, multibillion dollar transmission expansions, and the 2.6 gigawatt Coastal Virginia Offshore Wind (CVOW) project advancing toward first power in early 2026.
  • Now, reports indicate that Dominion is exploring a potential acquisition of Northern Virginia Electric Cooperative (NOVEC), a move that would deepen its footprint in the world’s busiest data center corridor—Loudoun County’s “Data Center Alley.” The timing is notable: Dominion disclosed that contracted and in process data center demand has surged to roughly 47 gigawatts, up 17% since year end 2024, while the company simultaneously works through major regulatory, financing, and construction milestones across its portfolio.
  • Dominion and NOVEC already share deeply interconnected transmission infrastructure, and NOVEC’s customer mix—where data centers account for roughly two thirds of electricity sales—aligns with Dominion’s strategy to serve rapidly rising AI related load.

Life Time Inc. Unleashes a High-End Expansion—Is Its Affluent Club Strategy a Game Changer?

By Baptista Research

  • Life Time Group Holdings Inc. reported its third-quarter 2025 financial results, showcasing significant growth across several metrics, indicative of effective strategic execution and market positioning.
  • Total revenue rose by 12.9% to $783 million, supported by an increase in average monthly dues per member and robust comparable center revenue, which grew 10.6% over the prior year.
  • Moreover, membership remained stable with 841,000 center memberships and total memberships reaching 891,000, in line with the company’s expectations.

IonQ Inc: How Europe & NATO Expansion Could Unlock Massive New Revenue Streams!

By Baptista Research

  • IonQ, Inc. recently reported its third-quarter results for 2025, highlighting significant strides in revenue and technological advancements within the quantum computing sector.
  • The company achieved a 222% year-on-year revenue growth, reaching $39.9 million, which was 37% above the high end of its guidance.
  • This impressive performance was attributed to its strategic positioning as a full quantum platform company, encompassing quantum computing, networking, sensing, and cybersecurity.

Management Buyouts and Litigation Updates: PRTH, KNOP, LEN, ABCP, and NANO Developments in Focus

By Special Situation Investments

  • Priority Technology (PRTH) received a non-binding privatization offer from its founder at $6-$6.15/share, with activist opposition.
  • KNOT Offshore Partners (KNOP) received a non-binding privatization offer at $10/unit, with expectations of a bumped offer.
  • Lennar Corporation (LEN) completed a tender offer, with a final exchange ratio of 4.1367x and oversubscription.

Back to Near-Term Bullish on SPX and Nasdaq 100; Supports Held at SPX 6480-6520 and QQQ $580-583

By Joe Jasper

  • We downgraded our near-term outlook on SPX and QQQ to neutral last week (11/19/25), after being bullish since 4/22/25, while we maintained our intermediate-term bullish outlook (as of 5/14/25).
  • Crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ held last week, and we are back to being near-term bullish as long as these supports continue to hold
  • The latest pullback offers an attractive entry point into all the speculative growth areas that we were pounding the table on since May, WITH A STOP AT LAST WEEKS LOWS

Abbott Labs’ Exact Sciences Acquisition: What Could Go Right In This $21 Billion Cancer Play?

By Baptista Research

  • Abbott Laboratories has made headlines once again, this time for a bold push into cancer diagnostics through its proposed $21 billion acquisition of Exact Sciences.
  • The deal, which values Exact at $105 per share in cash and represents a 51% premium over its last closing price, is poised to be the largest healthcare M&A deal in two years and the biggest ever in the diagnostics space.
  • Slated to close in Q2 2026, the transaction marks Abbott’s strategic expansion beyond glucose monitoring and cardiovascular devices into oncology testing—a market the company had eyed for years.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Bharti Airtel, S.H. Kelkar & Co, Bajaj Housing Finance, Wim Plast Ltd, Bombay Burmah Trading, Advanced Enzyme Technologies, Delhi International Airport Limited and more

By | Daily Briefs, India

In today’s briefing:

  • Bharti Airtel Block – Third Selldown by Promoter Entity This Year
  • The Beat Ideas: S.H. Kelkar – A Capex Cycle Poised to Unlock Operating Leverage
  • Bajaj Housing Finance (BHF IN) | Running to Stand Still
  • Primer: Wim Plast Ltd (WMP IN) – Nov 2025
  • Primer: Bombay Burmah Trading (BBTC IN) – Nov 2025
  • Primer: Advanced Enzyme Technologies (ADVENZY IN) – Nov 2025
  • Lucror Analytics – Morning Views Asia


Bharti Airtel Block – Third Selldown by Promoter Entity This Year

By Akshat Shah

  • Sunil Mittal-led promoter entity, Indian Continent Investment (ICI) is looking to raise around US$806m via selling a 0.6% stake in Bharti Airtel (BHARTI IN).
  • ICI had earlier sold around US$1bn in Feb and Aug 2025 while Singtel had sold US$1bn+ via 0.8% stake sales in Airtel in May 2025 and Nov 2025 as well.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

The Beat Ideas: S.H. Kelkar – A Capex Cycle Poised to Unlock Operating Leverage

By Sudarshan Bhandari

  • SHK reported 12% revenue growth in H1 FY26, but the reported EBITDA margin was compressed due to significant, deliberate investments in new growth initiatives and higher insurance costs.
  • The margin compression is temporary, a function of strategic, discretionary capex and opex, which are critical for achieving the management’s ambitious 18–20% EBITDA margin target by FY27–FY28.
  • The market is discounting the value of this forward-looking investment phase; sustained execution on new capacity, coupled with global regulatory shifts favoring organized players, provides a strong catalyst path.

Bajaj Housing Finance (BHF IN) | Running to Stand Still

By Pranav Bhavsar

  • Bajaj Housing Finance (BHF IN) is a priced to perfection narrative.
  • The current valuation (37.3x P/E, 4.2x P/B) prices the stock for absolute perfection in an environment that is distinctly imperfect and rapidly deteriorating.
  • A critical red flag highlighted in the Q2 transcript is the elevated annualized attrition rate.

Primer: Wim Plast Ltd (WMP IN) – Nov 2025

By αSK

  • Strong Brand Equity and Distribution Network: Wim Plast leverages the widely recognized “Cello”brand, a household name in India for decades, coupled with a robust pan-India network of manufacturing units and depots, providing a significant competitive advantage.
  • Attractive Valuation with Consistent Shareholder Returns: The company trades at a compelling valuation (P/E of 9.7x, P/B of 1.03x) compared to its peers. This is supported by a history of consistent dividend payments and a healthy payout ratio.
  • Favorable Industry Dynamics vs. Modest Growth: While the Indian plastic furniture market is poised for strong growth driven by urbanization and rising incomes, the company has demonstrated relatively flat revenue growth in recent years, highlighting a potential gap between market opportunity and execution.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Bombay Burmah Trading (BBTC IN) – Nov 2025

By αSK

  • Bombay Burmah Trading Corporation (BBTC) is a diversified holding company of the Wadia Group, with its intrinsic value primarily derived from its ~50.5% stake in the fast-moving consumer goods (FMCG) major, Britannia Industries.
  • The company trades at a significant and persistent discount to the market value of its underlying assets, offering potential for substantial value unlocking. However, this discount is perpetuated by the underperformance of its standalone businesses and concerns over capital allocation.
  • BBTC’s standalone operations, mainly in tea plantations and auto-electric components, face industry-specific headwinds and have historically yielded modest returns, weighing on the consolidated financial performance and investor sentiment.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Advanced Enzyme Technologies (ADVENZY IN) – Nov 2025

By αSK

  • Advanced Enzyme Technologies is a leading Indian enzyme and probiotics manufacturer with a global footprint, serving over 700 customers in more than 45 countries. The company has a diversified business model, catering to various industries including human healthcare, animal nutrition, and food processing.
  • The company is well-positioned to capitalize on the growing global demand for eco-friendly and natural solutions. The industrial enzymes market is projected to grow at a CAGR of 6-7% annually. Key growth drivers include a strong focus on R&D, expansion of its international presence, and potential inorganic growth opportunities.
  • While the company demonstrates a strong financial profile with a net cash position and healthy margins, it faces risks from regulatory changes, raw material price volatility, and intense competition from larger global players.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Delhi Int’l Airport
  • UST yields fell yesterday, led by the long end, on the back of a solid 2-year note auction and surprisingly dovish comments from San Francisco Fed President Mary Daly. The yield on the 2Y UST declined 1 bp to 3.50%, while that on the 10Y UST was down 4 bps at 4.03%.
  • Equities rose for a second day, as tech stocks recovered slightly from the prior week’s sell-off. The S&P 500 advanced 1.5% to 6,705, and the Nasdaq jumped 2.7% to 22,872.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars